Non-Alcoholic Fatty Liver Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 or older, of any sex
- People who have been diagnosed with a liver condition called metabolic dysfunction-associated fatty liver disease (MAFLD) according to specific Chinese medical guidelines (confirm with trial site)
- People who have also been diagnosed with type 2 diabetes, based on specific Chinese medical guidelines (confirm with trial site)
Who may not be able to join:
- People who have unhealed wounds, scars, or skin conditions on the upper right side of their abdomen that would make an ultrasound scan difficult or impossible
- People who develop another type of liver disease during the study, such as viral hepatitis, liver damage from medication, or alcohol-related liver disease
- People who have a history of their liver failing to work properly (known as liver decompensation) (confirm with trial site)
- People who have previously had part or all of their liver removed, or who have received a liver transplant
- People who have a history of any other type of cancer
- People who have certain rare or specific liver or heart conditions that affect the liver (confirm with trial site for the full list)
- People who have previously had a specific procedure to redirect blood flow in the liver (called a TIPS procedure) (confirm with trial site)
- People who experience a sudden severe spike in liver inflammation during the study, or sudden liver failure on top of a chronic condition (confirm with trial site)
- People who have an underactive or overactive thyroid, whether or not they have symptoms
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Yan Bi, MD,PhD, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University
Phone: 86-25-83-105302
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
To evaluate the overall detection rate of MASH in the Chinese T2DM and MAFLD population.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.